Search Constraints
« Previous |
21 - 40 of 53
|
Next »
Search Results
Select an image to start the slideshow
The use of contemporary chemoproteomic techniques in antimalarial target identification
1 of 20
New route investigation and process development in the synthesis of GSK221149
2 of 20
The design and synthesis of targeted BET inhibitors
3 of 20
Novel C-C bond formation strategies for access to secondary and tertiary amides enabled by new synthetic technologies
4 of 20
Novel approaches targeting phosphoinositide 3-kinase delta
5 of 20
Synthesis of non-natural base-pairs : towards site-specific functionalisation of nucleic acids
6 of 20
Preclinical development of a treatment for systemic lupus erythematosus
7 of 20
Development of small molecule splice-switchers as inducers of apoptosis
8 of 20
The design, synthesis and optimisation of calcium release-activated calcium (CRAC) channel inhibitors and mitochondrial permeability transition pore (mPTP) modulators, using phenotypic screening
9 of 20
The design and synthesis of novel epigenetic modulators
10 of 20
Development of chemical probes for non-BET bromodomains
11 of 20
Design and synthesis of dimethylisoxazole quinolines as BET inhibitors
12 of 20
The development of chemo- and regioselective reactions of boron systems
13 of 20
New chemical approaches for the development of targeted protein degradation
14 of 20
Targeted protein degradation as a new approach to drug discovery
15 of 20
Development of lysine-targeted irreversible inhibitors of PI3Kδ
16 of 20
The design and synthesis of αvβ6 antagonists and PI3K inhibitors as small molecule therapies for respiratory diseases
17 of 20
Novel PI3Kδ inhibitors for the treatment of inflammatory diseases
18 of 20
Use of fragment-based drug discovery to identify novel drug molecules for challenging biological targets, including protein-protein interactions
19 of 20
Studies towards the synthesis and labelling of bioactive peptides
20 of 20